Previous studies have suggested that procollagen types I and III are the major collagenous gene products of cultured human skin fibroblasts. In this study the expression of 10 different genes, encoding the subunit polypeptides for collagen types I-VI, by human skin fibroblasts in culture was analyzed by molecular hybridizations. Northern transfer analysis demonstrated the presence of specific mRNA transcripts for collagen types I, III, IV, V, and VI, but not for type II collagen. Quantitation of the abundance of these mRNAs by slot blot hybridizations revealed that type I, III, and VI procollagens were the major collagenous gene products of skin fibroblasts in culture. The mRNAs for type IV and V collagens represented only a small percentage of the total collagenous mRNA transcripts. Further analysis by in situ hybridization demonstrated that the majority of the cultured cells coexpressed the genes for type I, III, and VI procollagen pro-a chains. Further in situ hybridization analyses revealed the expression of type VI collagen genes in normal human skin. These data demonstrate that human skin fibroblast cultures can be used to study the transcriptional regulation of at least nine genetically distinct procollagen genes. The data further suggest that type VI collagen, in addition to types I and III, may be a major collagenous component of human skin.
Introduction
Fibroblasts, differentiated mesenchymal cells, are the major cell type responsible for the synthesis ofcollagen, the predominant extracellular matrix component in skin and other connective tissues. Previous studies have suggested that genetically distinct procollagens type I and III are the major collagenous gene products expressed by cultured dermal fibroblasts (1) . These conclusions were initially based on biosynthetic studies using chromatographic and electrophoretic separation of type I and III collagen chains. Additional lines of evidence using biochemical techniques and immunodetection with specific antibodies have suggested that fibroblastic cells are capable of synthesizing other genetically distinct procollagens, including types IV, V, and VI (2) (3) (4) (5) (6) . In accordance, the presence of specific mRNA transcript for the corresponding a-chains has been detected in skin fibroblasts by Northern transfer analysis (7) (8) (9) (10) . The results of these studies indicated that type IV collagen is a minor gene product in human skin fibroblast cultures (7, 8) . The synthesis of collagens type V and VI, relative to types I and III, has not been quantitated, although the steady-state mRNA ratio for type I/VI collagen in a fetal skin fibroblast cell strain was shown to be - 5.3 
(1O).
A recent study has suggested that type VI collagen represents a major fraction of connective tissue collagens in a variety of tissues ( 11); however, the amount of type VI collagen in human skin was not determined. Type VI collagen is a heterotrimer consisting of a I (VI), a2(VI), and a3(VI) chains, which are synthesized as polypeptides with M, of -140, 140, and 260 kD, respectively (5, (12) (13) (14) . These collagenous molecules contain unusually large globular domains at the ends of the polypeptides (5, 6) . Type VI collagen molecules have been suggested to assemble into dimers and tetramers by lateral association before secretion ( 13) . The assembly is stabilized by extensive disulfide bonding and this aggregation mechanism may be unique to type VI collagen (13) . The genes coding for these polypeptides have been localized to human chromosomes 21 (a 1 and a2 chains) and 2 (a3 chain) (15) . Alterations in type VI collagen have also been implicated in heritable diseases (16, 17) .
The present study examined the expression of 1O different procollagen genes, including the three subunits of type VI collagen, using three different mRNA hybridization techniques. First, the presence of specific mRNAs for distinct procollagen genes was analyzed by Northern transfer hybridizations with human sequence-specific cDNAs for types I-VI procollagen polypeptides. Second (20) , and hybridized with cDNAs labeled by nick translation with a[32P]dCTP to a specific activity of at least 1 X 108 cpm/jig as described previously (7) .
The relative abundance of the different collagenous mRNAs was determined by slot blot hybridizations. Total RNA was dotted onto nitrocellulose filters in varying concentrations and the filters were hybridized with radioactive cDNAs (7) . The [32P]cDNA-mRNA hybrids were visualized by autoradiography and the mRNA levels were quantitated by scanning densitometry of the autoradiograms. To allow comparison of the relative expression of genes coding for the genetically distinct collagen types, the densitometric units/microgram RNA dotted were corrected for the specific activities and sizes ofthe cDNAs, as well as for a-chain composition of the collagen molecules (21) .
For in situ hybridization the cells were grown on acetylated object glasses (22), permeabilized, and fixed with 95% ethanol at -20'C for 15 min and 4% paraformaldehyde at room temperature for 15 min, after which the cells were pretreated to block charged groups as described (22, 23). The samples were hybridized in the presence of 50% formamide and 10% dextran sulfate for 50 h at 420C using cDNAs labeled with [35SJdATP by nick translation. After hybridization the samples were washed in solutions of decreasing ionic strength at increasing temperature, treated with S 1-nuclease to degrade nonspecifically-bound single-stranded cDNA, washed, and dehydrated. The [35S]cDNA-mRNA hybrids were detected using Kodak NTB 3 emulsion by exposing the samples for 5 quently developed using Kodak D-19 developer (15°C, 120 s) and stained with hematoxylin to visualize the nuclei. The specimens were photographed using a Nikon optiphot microscope equipped with camera attachments (23) .
To demonstrate the expression of type VI collagen genes in vivo, specimens were obtained from the skin of a 1 9-wk-old fetus and from the apparently normal perilesional skin of a 52-yr-old female patient with type 1 neurofibromatosis. 5-,um frozen sections were pretreated and hybridized with a 35S-labeled aI(VI) collagen cDNA as described previously in detail (23 (27) ; for type IV collagen, a 2.6-kb proa I(IV) (HT-21) cDNA (28) and a 1.7-kb proa2(IV) (HT-39) cDNA (29) ; for type V collagen, a 2.5-kb proa2(V) (Hf 511) cDNA (30) ; for type VI collagen, three different cDNAs, 2.1-(p18), 1.5-(p8), and 1.5-(p24) kb in size, coding for the proa l(VI), proa2(VI), and proa3(VI) chains, respectively (10).
Results and Discussion
To examine the expression of the different procollagen genes, poly(A+)RNA isolated from adult human skin fibroblast cultures was subjected to Northern hybridizations with cDNAs corresponding to the pro-a chains of type I-VI procollagens. Autoradiograms ofthe Northern blots revealed the presence of characteristic mRNA transcripts corresponding to a l(I) (4.8 and 5.8 kb), al(III) (5.4 and 4.8 kb), a2(IV) (6.7 kb), and a2(V) (5.2 kb), as well as the al (4.2 kb), a2 (3.5 kb), and a3 (8.5 kb) chains of type VI procollagen, when hybridized with the respective cDNAs (Fig. 1) . Similarly, characteristic transcripts corresponding to the a2(I) (5.2, 4.6, and 4.2 kb) and aI(IV) (6.8 kb) procollagen polypeptides were detected (not shown). However, an a1(II) procollagen cDNA did not reveal any specific hybridization with the same RNA preparations even after extended exposure of the Northern filters to x-ray films (Fig. 1 ). These data demonstrate that human skin fibroblasts express the genes coding for the subunit polypeptides of type I, III, IV, V, and VI procollagens but not Our initial impression, based on the intensity of the bands detected by Northern transfer analysis, was that the steadystate abundance of mRNAs for type I and VI collagens was the highest among the five genetically distinct types of collagens expressed in these cells. This observation was somewhat surprising because type VI collagen has been thought to account for a minor portion oftotal collagen in human dermis (31) . To determine the relative expression of genes coding for the different procollagen pro-a chains, the ratios of the corresponding mRNA steady-state levels were quantitated by slot blot hybridizations. A representative set of blots is shown in Fig. 2 . Since all the hybridizations were done in parallel using the same amount of RNA from the same preparation, and the exposure time of all blots was the same, these analyses allow a direct comparison of the relative abundance of the corresponding mRNAs (Fig. 2) . The mRNA levels for type IV and V procollagens were found to represent < 1% of the-total collagenous mRNAs. Examination of 15 separate control skin fibroblast strains indicated that the ratio of type I/VI procollagen mRNAs was 3.24±0.99 (mean±SD, n = 24). There was no apparent correlation between the age (20 fetal wk and 87 yr) or sex (4 male vs. 11 female) of the donors, or the passage number of the cell cultures (6-11 passages). The mRNA ratio of a l(VI), a2(VI), and a3(VI) chains was -1:1:1, a ratio previously suggested by Northern transfer analysis (10). This stoichiometry also has been noted at the protein level (11) (12) (13) (14) In situ hybridization was used to address the issue of whether an individual fibroblast was capable of coexpressing multiple procollagen genes, or whether evidence of heterogeneity with respect to collagen production could be observed within cultures of normal fibroblasts. This question was prompted by previous suggestions (31) that type VI collagen segregates into microfibrils that are clearly distinct by morphologic criteria from type I and III collagen-containing fibers. Hybridizations with a1(I) and a I(III) procollagen cDNAs revealed that essentially all cells present in fibroblast monolayer cultures uniformly expressed these genes both in high-and low-density cultures (Fig. 3) . Similar observations were made with the a2(I) cDNA (not shown). Furthermore, the majority of the cells clearly expressed the a3(VI) gene of type VI procollagen (Fig. 3, E and F) . Thus, on a statistical basis it is clear that a single fibroblast can coexpress at least four [a1(I), a2(I), a 1(III), a3(VI)] and probably six (all subunits ofcollagen types I, III, and VI) different procollagen genes. These observations attest to the omnipotent characteristic of cultured human skin fibroblasts with respect to procollagen gene expression. These results also extend previous demonstrations of colocalization of type I-and III procollagen epitopes on a single fibroblast cell as detected by immunocytochemistry (32) . Thus, our results indicate that although type VI collagen is present in fibrils distinct from type I and III collagen fibers, all three collagen types are synthesized by the same cells. Therefore, the aggregation mechanisms unique to type VI collagen are apparently responsible for segregation of these collagen types to different fibrillar structures of the matrix ( 13, 31) .
In situ hybridizations with type IV and V procollagen cDNAs were inconclusive. These findings are probably attributed to the low abundance of the corresponding mRNAs in these cells, as suggested by Northern transfer analysis. In situ hybridizations with the a 1(II) procollagen cDNA yielded only a background signal, consistent with nonexpression of this gene.
To demonstrate the expression oftype VI collagen genes in vivo, in situ hybridizations were also performed with sections of normal human skin. Direct evidence of the expression of al(VI) collagen gene was obtained both in fetal and adult human dermis (Fig. 4) . Thus, expression of type VI collagen genes in human skin fibroblast cultures appears to reflect the expression of these mRNAs in the relevant tissue.
In summary, the results of this study indicate that cultured human skin fibroblasts express the genes encoding type I, III, IV, V, and VI procollagens. The relatively high abundance of type VI procollagen mRNAs suggests this collagen may be a major connective tissue component of the skin. Thus, fibroblast cultures provide a convenient system to study aberrations in the expression of numerous procollagen genes in diseases, including those encoding type VI collagen. 
